CIK 0001035267
- Large accelerated filer
INTUITIVE SURGICAL INC
Sign in to watch- Ticker
- ISRG
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770416458
- Phone
- +1 408-523-2100
- Business address
- 1020 KIFER ROAD, SUNNYVALE, CA, 94086
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,245,290
- in 15 filings, $20.2M under 10b5-1 plans
Net −$20,245,290. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- GUTHART GARY S −$13.6M Director sold 2% of stake
- Widman Fredrik −$4.6M VP Corporate Controller sold 91% of stake
- BARRATT CRAIG H −$1.0M Director sold 100% of stake
- WADORS PATRICIA L −$478K SVP Chief Human Resources Offi sold 100% of stake
- Brosius Mark −$278K EVP & Chief Mfg and Supply Cha sold 74% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-28 | LEVY ALAN J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,448 | 1,448 | ||
| 2022-04-28 | LEVY ALAN J Director | Grant or award · Restricted Stock Units | +482 | 482 | ||
| 2022-04-28 | NACHTSHEIM JAMI K Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,448 | 1,448 | ||
| 2022-04-28 | NACHTSHEIM JAMI K Director | Grant or award · Restricted Stock Units | +482 | 482 | ||
| 2022-04-28 | KANIA DON R Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,448 | 1,448 | ||
| 2022-04-28 | KANIA DON R Director | Grant or award · Restricted Stock Units | +482 | 482 | ||
| 2022-04-27 | Curet Myriam EVP & Chief Medical Officer | Gift | −144 | 217 | ||
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion | +795 | $245.60 | $195K | 7,150 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Sale | −795 | $253.04 | $201K | 6,355 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion | +270 | $242.34 | $65K | 6,625 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Sale | −270 | $253.04 | $68K | 6,355 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion | +273 | $179.70 | $49K | 6,628 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Sale | −273 | $253.04 | $69K | 6,355 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion | +273 | $177.99 | $49K | 6,628 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Sale | −273 | $253.04 | $69K | 6,355 |
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −273 | 2,085 | ||
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −273 | 2,262 | ||
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −270 | 2,082 | ||
| 2022-04-26 | DeSantis Robert EVP & Chief Product Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −795 | 6,750 | ||
| 2022-04-26 | Curet Myriam EVP & Chief Medical Officer | Exercise or conversion | +6,000 | $139.52 | $837K | 6,361 |
Page 93 of 95 · 1,882 trades